EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Seguimiento de los pacientes después de neumonía por COVID-19. Secuelas pulmonares

Iván Chérrez-Ojeda, Laura Gochicoa-Rangel, Antonio Salles-Rojas, Hans Mautong

Revista Alergia México · 2021-02-09 · 67 (4) · 350-369

DOI: 10.29262/ram.v67i4.847 ↗
AbstractBibliografische Angaben

Abstract

Coronavirus disease 2019 (COVID-19) is an infection caused by the SARS-CoV-2. COVID-19 has caused an unprecedented pandemic, with a large number of infections and deaths worldwide. Although most cases are mild, there are a considerable number of patients who develop pneumonia or even acute respiratory distress syndrome (ARDS). After recovering from the initial disease, many patients continue with various symptoms (fatigue, dry cough, fever, dyspnea, anosmia, chest pain, among others.), which has led to consider the possible existence of the “pos-COVID-19 syndrome”. Although the definition and validity of this syndrome are not clear, several studies report that individuals recovered from COVID-19 may have persistent symptoms, radiological abnormalities, and compromised respiratory function. Current evidence suggests that there is a large number of pulmonary sequelae after COVID-19 pneumonia (interstitial thickening, ground glass infiltrate, crazy paving pattern, bronchiectasis, among others.). Likewise, it seems that pulmonary function tests (spirometry, DLCO, 6MWT and the measurement of maximum respiratory pressures) in addition to high-resolution computed tomography are useful for the evaluation of these post-COVID-19 pulmonary sequelae. This review aims to describe the possible pulmonary sequelae after COVID-19 pneumonia, while suggesting diagnostic procedures for their correct evaluation and follow-up; thus, allowing a proper management by a multidisciplinary medical team.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →